Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion type Assertion NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_head.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion description "[We found that the RAD52 2259 CT or TT, hMLH1 -93 GG, and ERCC1 8092 AA genotypes were associated with breast cancer risk after adjustment for known risk factors [odds ratio (OR), 1.33; 95% confidence interval (95% CI), 1.02-1.75; OR, 1.31; 95% CI, 0.99-1.74; and OR, 0.58; 95% CI, 0.38-0.89, respectively].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_provenance.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion evidence source_evidence_literature NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_provenance.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion SIO_000772 15958648 NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_provenance.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion wasDerivedFrom befree-20140225 NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_provenance.
- NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_assertion wasGeneratedBy ECO_0000203 NP502550.RAoih4UOVXXX5biNnr6dmIgROuu6tRdLQLekl2yaiY8CI130_provenance.